Skip to main content
. 2013 Jul-Sep;4(3):151–159. doi: 10.4103/2231-4040.116785

Figure 4.

Figure 4

Scanning electron microscopy of (a) cross-sectional surface of optimized formulation (F17) of clobazam, (b) cross-sectional surface of formulation F17, (c) sectional surface of formulation F17 (without superdisintegrant)